Frank Speleman

22PUBLICATIONS
91CO-AUTHORS
Cancer geneticsGenome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 07, 2026
A functional landscape for chromosome 17q in neuroblastoma: balancing replication stress and genomic stability.

|May 15, 2026
Widespread DNA off-targeting confounds RNA chromatin occupancy studies.

|Feb 25, 2026
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitors.

Iris H Nelen, Soetkin Leys, Sarah-Lee Bekaert

|Jan 12, 2024
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN.

Jonatan L Gabre, Peter Merseburger, Arne Claeys

|Dec 04, 2023
MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression.

Alice Salib, Nisitha Jayatilleke, Janith A Seneviratne

|Nov 14, 2023
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma.

Lei Zhai, Anushree Balachandran, Rebecca Larkin

Pageof 4

Frequent Collaborators

8 joint publications

Bieke Decaesteker

6 joint publications

Christophe Van Neste

6 joint publications

Kaat Durink

5 joint publications

Siebe Loontiens